全文获取类型
收费全文 | 6613篇 |
免费 | 434篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 118篇 |
妇产科学 | 106篇 |
基础医学 | 629篇 |
口腔科学 | 134篇 |
临床医学 | 768篇 |
内科学 | 1410篇 |
皮肤病学 | 77篇 |
神经病学 | 489篇 |
特种医学 | 571篇 |
外国民族医学 | 1篇 |
外科学 | 997篇 |
综合类 | 130篇 |
一般理论 | 2篇 |
预防医学 | 659篇 |
眼科学 | 83篇 |
药学 | 371篇 |
1篇 | |
中国医学 | 4篇 |
肿瘤学 | 466篇 |
出版年
2022年 | 56篇 |
2021年 | 95篇 |
2020年 | 61篇 |
2019年 | 93篇 |
2018年 | 129篇 |
2017年 | 83篇 |
2016年 | 83篇 |
2015年 | 110篇 |
2014年 | 151篇 |
2013年 | 216篇 |
2012年 | 356篇 |
2011年 | 335篇 |
2010年 | 193篇 |
2009年 | 175篇 |
2008年 | 276篇 |
2007年 | 311篇 |
2006年 | 280篇 |
2005年 | 269篇 |
2004年 | 272篇 |
2003年 | 217篇 |
2002年 | 204篇 |
2001年 | 182篇 |
2000年 | 198篇 |
1999年 | 168篇 |
1998年 | 73篇 |
1997年 | 49篇 |
1996年 | 70篇 |
1995年 | 60篇 |
1994年 | 68篇 |
1993年 | 72篇 |
1992年 | 162篇 |
1991年 | 138篇 |
1990年 | 162篇 |
1989年 | 164篇 |
1988年 | 152篇 |
1987年 | 142篇 |
1986年 | 134篇 |
1985年 | 111篇 |
1984年 | 92篇 |
1983年 | 79篇 |
1982年 | 50篇 |
1981年 | 39篇 |
1980年 | 47篇 |
1979年 | 64篇 |
1978年 | 64篇 |
1977年 | 44篇 |
1976年 | 44篇 |
1974年 | 56篇 |
1973年 | 46篇 |
1972年 | 45篇 |
排序方式: 共有7072条查询结果,搜索用时 15 毫秒
91.
Agus MS Swain JF Larson CL Eckert EA Ludwig DS 《The American journal of clinical nutrition》2000,71(4):901-907
BACKGROUND: The concept of a body weight set point, determined predominantly by genetic mechanisms, has been proposed to explain the poor long-term results of conventional energy-restricted diets in the treatment of obesity. OBJECTIVE: The objective of this study was to examine whether dietary composition affects hormonal and metabolic adaptations to energy restriction. DESIGN: A randomized, crossover design was used to compare the effects of a high-glycemic-index (high-GI) and a low-glycemic-index (low-GI) energy-restricted diet. The macronutrient composition of the high-GI diet was (as percent of energy) 67% carbohydrate, 15% protein, and 18% fat and that of the low-GI diet was 43% carbohydrate, 27% protein, and 30% fat; the diets had similar total energy, energy density, and fiber contents. The subjects, 10 moderately overweight young men, were studied for 9 d on 2 separate occasions. On days -1 to 0, they consumed self-selected foods ad libitum. On days 1-6, they received an energy-restricted high- or low-GI diet. On days 7-8, the high- or low-GI diets were consumed ad libitum. RESULTS: Serum leptin decreased to a lesser extent from day 0 to day 6 with the high-GI diet than with the low-GI diet. Resting energy expenditure declined by 10.5% during the high-GI diet but by only 4.6% during the low-GI diet (7.38 +/- 0.39 and 7.78 +/- 0.36 MJ/d, respectively, on days 5-6; P = 0.04). Nitrogen balance tended to be more negative, and energy intake from snacks on days 7-8 was greater, with the high-GI than the low-GI diet. CONCLUSION: Diets with identical energy contents can have different effects on leptin concentrations, energy expenditure, voluntary food intake, and nitrogen balance, suggesting that the physiologic adaptations to energy restriction can be modified by dietary composition. 相似文献
92.
93.
Epilepsy surgery has emerged as an important option in the treatment of children with epilepsy that is refractory to antiepileptic drug management. The cornerstone of successful surgery is accurate localization of the brain region of seizure onset. Traditional techniques of seizure onset localization, e.g. surface electroencephalography (EEG) recording and magnetic resonance imaging (MRI), allow accurate localization in a significant number of patients. When the focus of seizure onset is not apparent from these non-invasive techniques, other methods of localization, e.g. intracranial EEG recording, may be needed before resection of the focus. Single-photon emission computed tomography (SPECT) is a nuclear medicine blood-flow technique that has been used to identify a region of epileptogenic brain associated with low blood flow in the resting state (interictal SPECT) or increased blood flow at the time of seizure activity (ictal SPECT). This report describes the validation and utility of a computer-assisted method of subtracting the interictal from the ictal SPECT scans and co-registering the difference image on the MRI. This method, called subtraction ictal SPECT co-registered on MRI (SISCOM), is used in guiding the location and the extent of intracranial electrode implantation, or in obviating the need for the implantation in some cases. 相似文献
94.
M.F. MANJI I. AL BADAWI† A. EL ENBABY & N. AL BAREEDY† 《International journal of gynecological cancer》2006,16(2):675-680
Female circumcision is a traditional practice common in African countries. It involves partial or total removal of external female genitalia. It has led to many complications, in particular, the scarring of the external genitalia. The consequence is a very narrow introitus making the intracavitary brachytherapy treatment component difficult when these women develop cancer of cervix. We present two such cases from our institution. Our aim is to make the radiation and gynecological oncologists, both in developed and developing countries, aware of this practice and the problems they can encounter in the management of such cases. Intracavitary brachytherapy is an important component in the potentially curative role of radiation therapy for cervical cancer. Every effort should be made to ensure that the sequelae of genital mutilation does not deprive these women of the same standard of care as the general population. 相似文献
95.
John C Byrd Bercedis L Peterson Janice Gabrilove Olatoyosi M Odenike Michael R Grever Kanti Rai Richard A Larson 《Clinical cancer research》2005,11(11):4176-4181
PURPOSE: Flavopiridol has in vitro activity in chronic lymphocytic leukemia (CLL) and promotes apoptosis independent of p53 function or prior fludarabine exposure. We sought to determine if flavopiridol has activity in previously treated CLL using two schedules of administration. PATIENTS AND METHODS: Patients with previously treated CLL were enrolled in two sequentially done phase II studies. Patients in the first trial received flavopiridol (50 mg/m(2)/d) as a continuous infusion (CI) for 72 hours every 2 weeks. Patients in the second trial received flavopiridol 50 mg/m(2) as a 1-hour bolus (IVB) daily for 3 days repeated every 3 weeks. Patients received up to 12 (CI cohort) or 8 (IVB cohort) cycles of therapy. RESULTS: Fifteen patients were enrolled in the 72-hour CI phase II trial; 6 (40%) had intermediate-risk (Rai stage I or II) and 9 (60%) had high-risk (Rai stage III and IV) stages. No responses were noted in this group; 27% had stable disease and 73% had progressive disease. Thirty-six patients were enrolled in the second IVB trial, with 13 (36%) having intermediate and 23 (64%) having high-risk disease. Four patients (11%) had partial responses, 19 (53%) had stable disease, and 13 (36%) had progressive disease. The progression-free survival for responders in the IVB trial was 3, 3, 9, and 19 months. The median progression-free survival was 2 months [95% confidence interval (95% CI), 1.8-3.8] for patients in the CI trial and 3 months (95% CI, 2.5-7.4) for the IVB trial. The median overall survival was 27 months (95% CI, 20-42) for the CI trial and 24 months (95% CI, 18-31) for the IVB trial. Toxicity was manageable and included mainly myelosuppression, infections, diarrhea, and fatigue. CONCLUSIONS: Flavopiridol has modest, schedule-dependent clinical activity in relapsed CLL and warrants future investigation utilizing alternative schedules of administration. 相似文献
96.
Peter D Cole Richard A Drachtman Angela K Smith Sarah Cate Richard A Larson Douglas S Hawkins John Holcenberg Kara Kelly Barton A Kamen 《Clinical cancer research》2005,11(22):8089-8096
PURPOSE: To determine the antileukemic activity of weekly oral aminopterin in patients with refractory acute leukemia; to describe the pharmacodynamic properties of aminopterin; and to contrast the intracellular metabolism of aminopterin and methotrexate by patients' blasts in vitro. EXPERIMENTAL DESIGN: Forty-six patients were enrolled in three strata: children with acute lymphoblastic leukemia (ALL), adults with ALL, and patients with acute myeloid leukemia (AML). Aminopterin was given weekly, in two doses of 2 mg/m(2), 12 hours apart. Limited sampling pharmacokinetic analysis was done during the first week of therapy. Accumulation of [(3)H]aminopterin and [(3)H]methotrexate by leukemic blasts was studied in vitro. RESULTS: Six of 22 children with ALL (27%; 95% confidence interval, 8-47%) had clinically significant responses. None of those with AML and only two of 11 adults with ALL had responses meeting protocol definitions, although peripheral blast counts tended to decrease with therapy in all groups. Mucosal toxicity was minimal, even with limited use of leucovorin rescue. Complete bioavailability of aminopterin was confirmed, with a mean area under the curve of 0.52 +/- 0.03 micromol hour/L after oral dosing. No relationship between aminopterin pharmacokinetics and response was seen. In vitro, aminopterin showed more consistent metabolism by leukemic blasts to polyglutamates than methotrexate. Lineage-specific differences in the pattern of intracellular antifolylpolyglutamates were observed. CONCLUSIONS: Weekly oral aminopterin has significant activity among children with refractory ALL. With greater cellular accumulation and metabolism, more reliable bioavailability than methotrexate, and tolerable toxicity at this dose and schedule, aminopterin deserves further study as a potent alternative to methotrexate. 相似文献
97.
Guido Marcucci Wendy Stock Guowei Dai Rebecca B Klisovic Shujun Liu Marko I Klisovic William Blum Cheryl Kefauver Dorie A Sher Margaret Green Mollie Moran Kati Maharry Steven Novick Clara D Bloomfield James A Zwiebel Richard A Larson Michael R Grever Kenneth K Chan John C Byrd 《Journal of clinical oncology》2005,23(15):3404-3411
98.
Hill BT Kondapalli L Artz A Smith S Rich E Godley L Odenike O Pursell KJ Larson RA Stock W van Besien K 《Leukemia & lymphoma》2007,48(9):1799-1805
Prior invasive fungal infection (IFI) has historically limited the use of allogeneic stem cell transplantation for patients with hematologic malignancies. Transplantation of such patients frequently resulted in recurrent infection and high mortality rates. Several new antifungal agents have been introduced over the past 5 years with broader spectra of activity against molds such as Aspergillus and a favorable toxicity profile. In this study, we present a series of 16 consecutive patients with hematologic malignancy and prior invasive fungal infection who underwent allogeneic transplantation. Of these patients, the majority of whom were treated with voriconazole and/or caspofungin, only four experienced recurrent fungal infection and recurrent fungal infection was the primary cause of death in only one patient. The estimated 45% 2-year survival in this series is similar to that for other patients with high risk hematologic malignancy undergoing stem cell transplantation. We conclude that suspected prior invasive fungal infection should not preclude the use of allogeneic stem cell transplantation. 相似文献
99.
100.